Signing Instruction for Deafness
(SISI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The trial aims to explore how teaching strategies can boost sign language skills in deaf children, potentially improving their reading and writing abilities. The focus is on using Strategic and Interactive Signing Instruction (SISI) to determine its effectiveness for children at high risk of language delays. Teachers will receive training to implement these methods, and researchers will compare their effectiveness to traditional teaching practices. The trial is open to deaf children in prekindergarten to 3rd grade and their teachers. As an unphased trial, this study offers participants a unique opportunity to contribute to innovative educational strategies that could significantly enhance learning outcomes for deaf children.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that the Strategic and Interactive Signing Instruction is safe for deaf children?
Research has shown that teaching methods like Strategic and Interactive Signing Instruction (SISI) can improve language skills in deaf children. However, specific safety data for SISI itself is not available.
This program is non-invasive, involving no physical procedures or medications, which generally indicates low risk. SISI focuses on improving communication skills, emphasizing teaching rather than causing side effects.
For those considering joining this program, the goal is to enhance sign language skills, making it a likely safe educational experience.12345Why are researchers excited about this trial?
Researchers are excited about the Signing Instruction for Deafness trial because it's exploring new ways to boost sign language skills among deaf children. Unlike traditional teaching methods, this trial focuses on the Strategic and Interactive Signing Instruction (SISI) technique, which aims to enhance teachers' ability to effectively implement sign language instruction. The trial's unique approach involves a structured training program for teachers to improve their teaching fidelity, potentially leading to better language outcomes for children. By comparing different implementation methods and tracking progress over time, the trial seeks to uncover more effective strategies for sign language education.
What evidence suggests that Strategic and Interactive Signing Instruction is effective for improving sign language skills in deaf children?
Research shows that methods like Strategic and Interactive Signing Instruction (SISI), studied in this trial, can improve language skills in deaf children. Similar techniques, such as Strategic and Interactive Writing Instruction (SIWI), have enhanced writing and language skills in deaf and hard of hearing students. This suggests that SISI could also improve sign language skills, which connect to better reading, writing abilities, and overall health. The approach uses engaging strategies based on existing ideas about language cognition and learning. Early results indicate that these methods can significantly improve communication skills for children with potential language delays.678910
Are You a Good Fit for This Trial?
This trial is for deaf children aged 5 to 8 who are at high risk of language delays. It aims to improve their sign language skills, which may help with literacy and health outcomes.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention Development
Development of the Strategic and Interactive Signing Instruction (SISI) manual and protocols
Teacher Training
Teachers receive training on SISI implementation and fidelity
Treatment
Implementation of SISI to improve sign language skills in deaf children
Follow-up
Participants are monitored for improvements in sign language and written language skills
What Are the Treatments Tested in This Trial?
Interventions
- Strategic and Interactive Signing Instruction
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Tennessee, Knoxville
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator